Kabooha
Health authorities from Fort Portal Tourism City have confirmed that there is no Ebola patient at Fort Portal Regional Referral hospital Buhinga as of today October 17, 2022.
The revelation, comes two days after president Yoweri Museveni announced a lockdown in Mubende and Kasanda districts, the epicenter of Ebola virus that has claimed lives including health worker’s.
All these measures shall start with immediate effect and will last 21 days:
1- Movements into and out of Mubende and Kassanda Districts is prohibited.
2- There will be Curfew in Mubende and Kassanda Districts from 7:00pm to 6:00am.https://t.co/SVdc7IM3yL pic.twitter.com/psdKQAjKKn— Yoweri K Museveni (@KagutaMuseveni) October 15, 2022
Speaking to the nation on Saturday about Ebola Virus, General Museveni announced a total lock down and set restrictions on vehicles, cyclists, and pedestrian movements across the two districts plus closure of bars, cinema halls, and churches among others.
Fort City Health Educator speaks out
In Fort Portal Tourism City health educator, Stephen Muhenda has revealed that all is set to combat the dangerous disease, with sensitization programs ongoing.
Muhenda,while addressing journalists, also cautioned the population to cease from attending massive gatherings and embrace routine hand washing to control the spread of Ebola disease.
Ebola facts
The World health organization- WHO, has recently warned population on key areas of focus in the move to an Ebola free world.
- Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a rare but severe, often fatal illness in humans.
- The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.
- The average EVD case fatality rate is around 50%. Case fatality rates have varied from 25% to 90% in past outbreaks.
- Community engagement is key to successfully controlling outbreaks.
- Good outbreak control relies on applying a package of interventions, namely case management, infection prevention and control practices, surveillance and contact tracing, a good laboratory service, safe and dignified burials and social mobilisation.
- Vaccines to protect against Ebola have been developed and have been used to help control the spread of Ebola outbreaks in Guinea and in the Democratic Republic of the Congo (DRC).
- Early supportive care with rehydration, symptomatic treatment improves survival. Two monoclonal antibodies (Inmazeb and Ebanga) were approved for the treatment of Zaire ebolavirus (Ebolavirus) infection in adults and children by the US Food and Drug Administration in late 2020.
- Pregnant and breastfeeding women with Ebola should be offered early supportive care. Likewise vaccine prevention and experimental treatment should be offered under the same conditions as for non-pregnant population.
